LMT
30
-2
NOC
41
9
EQT
51
-3
DLTR
38
-4
ICE
59
-3
FIS
51
-4
MTCH
20
-8
ORLY
60
-5
SE
60
-3
HSY
31
-6
FAST
57
-3
BMY
55
-8
CVS
41
-4
MSI
72
-3
EOG
56
-2
JNPR
50
-6
PGR
59
-3
ED
45
3
TROW
47
-6
TXN
43
-5
LMT
30
-2
NOC
41
9
EQT
51
-3
DLTR
38
-4
ICE
59
-3
FIS
51
-4
MTCH
20
-8
ORLY
60
-5
SE
60
-3
HSY
31
-6
FAST
57
-3
BMY
55
-8
CVS
41
-4
MSI
72
-3
EOG
56
-2
JNPR
50
-6
PGR
59
-3
ED
45
3
TROW
47
-6
TXN
43
-5
Financhill
Back

Defiance Connective Technologies ETF Vs. Halozyme Therapeutics Industry Stock Comparison

Buy
64

SIXG
Defiance Connective Technologies ETF

Last Price:
44.29
Seasonality Move:
8.14%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Buy
64
Defiance Connective Technologies ETF (SIXG) is a Buy

Is Defiance Connective Technologies ETF a Buy, Sell or Hold?

  • The current Defiance Connective Technologies ETF [SIXG] share price is $44.30. The Score for SIXG is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • SIXG is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SIXG Stock Price Chart

What is Defiance Connective Technologies ETF's stock price today?

  • The Defiance Connective Technologies ETF share price today is $44.30
    The current trend is moderately bearish and SIXG is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

SIXG Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.43 Buy
Relative Strength Index (14 RSI): 45.75 Sell
Chaikin Money Flow: -15700 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.23 - 45.77) Sell
Bollinger Bands (100): (40.53 - 44.59) Buy

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

SIXG Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.81 Sell
20-day SMA: 45.03 Sell
50-day SMA: 43.84 Buy
200-day SMA: 40.62 Buy
8-day EMA: 45.3 Sell
20-day EMA: 45.04 Sell
50-day EMA: 44.02 Buy
200-day EMA: 40.7 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Defiance Connective Technologies ETF Earnings Growth & SIXG Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Defiance Connective Technologies ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):